Moderna
MRNA
$53.70
Share price
-0.94%
Change (1 day)
-68.19%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Total debt
Total debt on the balance sheet as of December 2024 : A$1.18 Billion
According to Moderna 's latest financial reports the company's total debt is A$1.18 Billion. A company’s total debt is the sum of all current and non-current debts.
Moderna - Total debt on balance sheet (from 2017 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | A$1.20 B | -34.17% |
| 2023-12-31 | A$1.82 B | 3.46% |
| 2022-12-31 | A$1.76 B | 39.57% |
| 2021-12-31 | A$1.26 B | 309.93% |
| 2020-12-31 | A$0.30 B | 63.03% |
| 2019-12-31 | A$0.18 B | 297.69% |
| 2018-12-31 | A$47.53 M | 136.58% |
| 2017-12-31 | A$20.09 M | 15.87% |
| 2016-12-31 | A$17.34 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | A$0.43 M | -99.96% | 🇺🇸 USA |
 | A$58.87 B | 4,868.01% | 🇺🇸 USA |
 | A$29.47 M | -97.51% | 🇺🇸 USA |
 | A$2.05 B | 73.50% | 🇺🇸 USA |
 | A$49.58 B | 4,084.47% | 🇨🇭 Switzerland |
 | A$0.83 B | -29.68% | 🇺🇸 USA |
 | A$58.11 B | 4,804.15% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |